Business
Issue of Equity and Total Voting Rights
Issue of Equity and Total Voting Rights.
About this update from Cambridge Cognition Holdings Plc
[{"type":"text","content":"\n\n26 July 2024\nCambridge Cognition Holdings plc\n(\"Cambridge Cognition\", the \"Company\" or the \"Group\")\nIssue of Equity and Total Voting Rights\n \nCambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces that further to the announcement on 12 October 2022 regarding the acquisition of eClinicalHealth Limited (\"Clinpal\"), the Company has today issued 229,984 new ordinary shares of £0.01 each in the share capital of the Company (\"New Ordinary Shares\") at an issue price of 132.97 pence per New Ordinary Share to certain shareholders of Clinpal, representing approximately £0.3m of the contingent consideration. No further consideration is due to former shareholders of Clinpal.\n \nAdmission and Total Voting Rights\n \nApplication has been made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM (\"Admission\") and it is expected that such Admission will take place on or around 8:00 a.m. on or around 31 July 2024.\n \nIn accordance with the provision of the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the Company confirms that, following the issue of the New Ordinary Shares, its issued ordinary share capital will comprise 41,940,413 Ordinary Shares. There are no shares held in treasury therefore the total number of voting rights in the Company is 41,940,413. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in Cambridge Cognition under the FCA's Disclosure and Transparency Rules.\n \nEnquiries:\n \n\n\n\n\n\n\n\n\nCambridge Cognition Holdings plc \nMatthew Stork, Chief Executive Officer \nStephen Symonds, Chief Financial Officer \n\n\nTel: 012 2381 0700 \[email protected] \n\n\n\n\n \nPanmure Liberum Limited (NOMAD and Joint Broker) \nEmma Earl / Freddy Crossley / Mark Rogers \nRupert Dearden \n\n\n \nTel: 020 7886 2968 \n(Corporate Finance) \n(Corporate Broking) \n\n\n\n\n \nDowgate Capital Limited (Joint Broker) \nDavid Poutney / Nicholas Chambers \n\n\n \nTel: 020 3903 7715 \n \n\n\n\n\n ...